Boron Neutron Capture Therapy

- Opening Speech; E.D. Hondros

- Welcome Address; H.H. van der Kroonenberg

- Safety and Efficacy in Boron Neutron Capture Therapy; D. Gabel

- Some Aspects of BNCT at the Brookhaven National Laboratory; D.D. Joel, et al.

- INEL BNCT Program Directions with Respect to Clinical Trials of BNCT; R.V. Dorn III.

- The Department of Energy Research Program in Boron Neutron Capture Therapy; R.W. Wood, D.W. Cole Jr.

- Current Overview on the Approach of Clinical Trials at Petten; R.L. Moss

- Review of the Physics Calculations Performed for the BNCT Facility at the HFR Petten; P. Watkins, et al.

- From Filter Installation to Beam Characterization; F. Stecher-Rasmussen, et al.

- Neutron Spectrometry Measurements of the Petten HFR, HB11 Neutron Beam; C.A. Perks, H.J. Delafield

- A Semi-Empirical Method of Treatment Planning for Boron Neutron Capture Therapy; C.P.J. Raaijmakers, et al.

- Present Status of the Three-Dimensional Treatment Planning Methodologies for the Petten BNCT Facility; P. Watkins

- A Phase 1 Biodistribution study of p-Boronophenylalanine; J.A. Coderre

- RBE in Normal Tissue Studies; R.A. Gahbauer, et al.

- Treatment planning and optimization for Pion Therapy; H. Blattmann

- Dose Calculations Based on Images Reconstructions; F.J. Wheeler, D.E. Wessol

- Borocaptate Sodium (BSH) Pharmacokinetics in Glioma Patients; H. Fankhauser, et al.

- BSH in Patiens with Malignant Glioma: Distribution in Tissue, Comparison between BSH Concentration and Histology; D. Haritz, et al.

- Macroscopic and Microscopic Biodistribution of BSH in a Rat Glioma Model; C.P. Ceberg, et al.

- Healthy Tissue Tolerance Studies for BNCT at the High Flux Reactor in Petten-First Results; A. Siefert

- Cellular Pharmacokinetics of BNCT Compounds and their Cellular Localization with EELS/ESI; R. Verrijk, et al.

- Large Animal Model Studies of Normal Tissue Tolerance using an Epithermal Neutron Beam and Borocaptate Sodium; P.R. Gavin,